David J Mazzo
CIK 1334549 · President & CEO · last filed 2026-01-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.75M
Companies
9
Total Filings
68
Lifetime Open-Market Net
$27.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LSTA | President & CEO | 319,744 | $3.56 | $1.14M | $0 | 8 | 2026-01-13 |
| LISATA THERAPEUTICS, INC. (CLBS) Delisted | Chief Executive Officer | 739,444 | $6.40 | $4.73M | $27.9K | 22 | 2022-09-02 |
| PALISADE BIO, INC. (SNCA) Delisted | Director | — | $9.96 | — | $0 | 2 | 2021-04-26 |
| EYPT | Director | 200,083 | $13.03 | $2.61M | $0 | 10 | 2020-03-03 |
| PALISADE BIO, INC. (CUR) Delisted | Director | — | — | — | $0 | 2 | 2019-10-11 |
| EyePoint, Inc. (PSDV) Delisted | Director | — | — | — | $0 | 11 | 2017-12-19 |
| LISATA THERAPEUTICS, INC. (NBS) Delisted | Chief Executive Officer | 239,543 | — | — | $0 | 3 | 2015-06-04 |
| AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted | Director | 336,394 | — | — | $0 | 8 | 2014-02-14 |
| Tobira Therapeutics, Inc. (RGDO) Delisted | Chief Executive Officer | — | — | — | $0 | 2 | 2014-01-03 |
Recent Filings · Page 2 of 7
68 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-12 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Mixed | +327,850 | -$66.2K | EDGAR |
| 2021-04-26 | PALISADE BIO, INC. (SNCA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-15 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Mixed | +4,852 | -$53.0K | EDGAR |
| 2021-01-12 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Mixed | +97,653 | -$34.0K | EDGAR |
| 2020-04-07 | PALISADE BIO, INC. (SNCA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-03 | EYPT | Grant (A) | — | $0 | EDGAR |
| 2020-01-15 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Mixed | +33,372 | -$42.1K | EDGAR |
| 2020-01-09 | LISATA THERAPEUTICS, INC. (CLBS) Delisted | Tax (F) | −4,522 | -$12.8K | EDGAR |
| 2019-10-11 | EYPT | Exer (M) | +33,333 | $65.0K | EDGAR |
| 2019-10-11 | PALISADE BIO, INC. (CUR) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.